Greg Freiherr, Industry Consultant
Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Sponsored Content | Blog | Greg Freiherr, Industry Consultant | PET-CT| October 08, 2018

How Digital PET/CT Can Improve Clinical Care

Digital PET/CT, achieved using Vereos from Philips Healthcare, can spot even a small lesion (arrow). Image courtesy of Brian Gordon, M.D.

Digital PET/CT, achieved using Vereos from Philips Healthcare, can spot even a small lesion (arrow). Image courtesy of Brian Gordon, M.D.

PET/CT can be indispensible as a diagnostic and prognostic tool; in the assessment of patient response to therapy and cancer recurrence; even in the choice of therapy. And the significance of this hybrid imaging modality could grow in future years.

Digitalization is increasing the medical value of PET/CT, according to Brian Gordon, M.D., who interprets the majority of digital PET/CTs performed at the WellStar Kennestone Cancer Center in Marietta, Ga.

“An improved patient experience is the major advantage of digital PET/CT,” said Gordon, head of Nuclear Medicine for Quantum Radiology, a subspecialty radiology group that interprets images for the sprawling WellStar Health System.

The digital detector built into the Vereos PET/CT from Philips Healthcare improves sensitivity and, consequently, the detectability of small lesions. And it does so while reducing scan time.

“We have seen a significant decrease in scan time,” he said. “About a third of the scan time has been removed.”

 

Patient First

The result is an enhanced patient experience, according to Gordon. The Vereos replaced an analog PET/CT at the WellStar Kennestone Cancer Center in November 2017. Since then, PET/CT scan volume has reached as high as 18 patients per day.

Despite the high throughput, which ranges from this peak to about a dozen scans per day, scan accuracy is excellent, he said.

The WellStar Kennestone Cancer Center is one of the busiest PET/CT providers in the state of Georgia, he said. The digital detector has dropped scan times for whole body exams from 50 to 30 minutes and ones from the base of the skull to mid-thigh from 30 to 20 minutes.

The vast majority of scans at the center are oncologic. Many are ordered to evaluate suspicious lesions that were spotted initially on CTs or MRIs, but Vereos is also used extensively to monitor patient response to cancer therapy and to look for cancer recurrence.

Although shorter scan times have boosted throughput at the cancer center and improved the patient experience, accuracy is the top priority, Gordon said. The increased sensitivity of the digital detector improves image quality, while short scan times make the patient more comfortable and less prone to move. This reduces the likelihood of motion artifacts that can degrade images.

The short scans do not reduce image quality, Gordon emphasized. On the contrary, compared with analog PET/CT that operated before Vereos, he said, “we are able to detect activity in smaller lesions.”

The ability to detect very small lesions is critically important when PET/CT is applied in staging or monitoring. This is where the digital detector excels, according to Philips’ Director of Clinical Science for Nuclear Medicine Piotr Maniawski.

“Digital technology allows us to improve small lesion detectability,” said Maniawski who has worked in nuclear medicine for more than three decades, mostly at Philips Healthcare.

Digital PET/CT is well suited to find recurrent disease and characterize patient response to therapy, while providing the option of fast scans, he said.

 

Transition to Digital

The difference digitalization can make is apparent during tumor boards at the WellStar Kennestone Cancer Center. Vereos delivers digital PET images, which can be fused with ones from CT, Gordon said. These colorized, fused images “improve the discussion because the clinicians can see what I am talking about,” he said.

Clear communication is especially important when planning patient management in tough cases, when therapy choices are not straightforward, he said, as exemplified when deciding whether a lesion may be resectable or if radiation or chemotherapy should be administered first. “If you can localize exactly where (the lesion) is, you can make better decisions,” Gordon said.

The clinical benefits possible with the digital photon counting detector built into the Vereos PET/CT could become even more significant in the future, Maniawski said.

The clinical prospects of PET/CT are derived from the relative certainty possible with the digital detector, Maniawski said. But academic science advances cautiously.

Several collaborative projects between Philips and academic centers are underway using Vereos “to deliver clinical proof not only for competitive differentiation (digital versus analog) but also to push molecular imaging forward,” he said.

 

*Disclaimer:  Results from case studies are not predictive of results in other case studies. Results in other case studies may vary.

Editor's note: This is the first blog in a series of four on digital PET/CT.

 

Related Content:

SPECIAL SUPPLEMENT: Examining the Value of Digital PET/CT

 

Related Content

Videos | RSNA | April 03, 2019
ITN Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies displa
Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill. Interview with Mark Pankuch, Ph.D.

Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill.
 

Feature | April 02, 2019 | Dave Fornell, Editor and A.J. Connell
April 2, 2019 — Here is the list of the most popular content on the Imaging Technology News (ITN) magazine w
NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve).

At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve). Photo by Greg Freiherr

Feature | Cardiac Imaging | March 22, 2019 | By Greg Freiherr
Reflecting a trend toward the increased use of...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
SyncVision iFR Co-registration from Philips Healthcare maps iFR pressure readings onto angiogram.

SyncVision iFR Co-registration from Philips Healthcare maps iFR pressure readings onto angiogram. Results from an international study presented at #ACC19 show that pressure readings in coronary arteries may identify locations of stenoses remaining after cardiac cath interventions.

Feature | Cardiac Imaging | March 18, 2019 | By Greg Freiherr
As many as one in four patients who undergo cath lab interventions can benefit from a technology that identifies the
Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Feature | Cardiac Imaging | March 17, 2019 | By Greg Freiherr
Virtual reality (VR) and its less immersive kin, augmented reality (AR), are gaining traction in some medical applica
WVU cardiology chief Partho Sengupta, M.D., describes at ACC 2019 how artificial intelligence already helps cardiologists in echocardiography.

WVU cardiology chief Partho Sengupta, M.D., describes at ACC 2019 how artificial intelligence already helps cardiologists in echocardiography. Photo by Greg Freiherr

Feature | Cardiac Imaging | March 16, 2019 | By Greg Freiherr
Machine learning is already having an enormous impact on cardiology, automatically calculating measurements in echoca
Podcast | Cardiac Imaging | March 15, 2019
Debate About Coronary Testing Highlights ACC Session